Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
FEBS Letters|October 1, 2013
Determination of topological structure of ARL6ip1 in cells: identification of the essential binding region of ARL6ip1 for conophyllineMasahiro Kuroda, Shintaro Funasaki, Tsuyoshi Saitoh, et al.Iscience|August 30, 2023
A stepwise and digital pattern of RSK phosphorylation determines the outcome of thymic selectionShintaro Funasaki, Atsushi Hatano, Hirokazu Nakatsumi, et al.STAR Protocols|January 12, 2025
Protocol for transcriptomic and epigenomic analyses of tip-like endothelial cells using scRNA-seq and ChIP-seqShintaro Funasaki, Yuri Miyamura, Shunsuke Kamei, et al.Current Issues in Molecular Biology|December 27, 2024
<i>ARID2</i> Deficiency Enhances Tumor Progression via ERBB3 Signaling in <i>TFE3</i>-Rearranged Renal Cell CarcinomaJinglong Tang, Shintaro Funasaki, Hidekazu Nishizawa, et al.Cancer Science|April 9, 2022
Targeting chemoresistance in Xp11.2 translocation renal cell carcinoma using a novel polyamide-chlorambucil conjugateShintaro Funasaki, Sally Mehanna, Wenjuan Ma, et al.Nature Communications|December 10, 2020
Blood and lymphatic systems are segregated by the FLCN tumor suppressorIkue Tai-Nagara, Yukiko Hasumi, Dai Kusumoto, et al.Genes to Cells : Devoted to Molecular & Cellular Mechanisms|January 14, 2025
HIF1α Plays a Crucial Role in the Development of TFE3-Rearranged Renal Cell Carcinoma by Orchestrating a Metabolic Shift Toward Fatty Acid SynthesisHidekazu Nishizawa, Shintaro Funasaki, Wenjuan Ma, et al.Neoplasia (New York, N.Y.)|March 17, 2026
The Cyclin C-CDK8/19 Mediator kinase module controls PRCC-TFE3 driven senescence in renal epithelium and tumorigenesis in TFE3-RCCShoichiro Kuroda, Shintaro Funasaki, Hidekazu Nishizawa, et al.Molecular Cancer Research : MCR|May 3, 2019
TFE3 Xp11.2 Translocation Renal Cell Carcinoma Mouse Model Reveals Novel Therapeutic Targets and Identifies GPNMB as a Diagnostic Marker for Human DiseaseMasaya Baba, Mitsuko Furuya, Takanobu Motoshima, et al.Molecular Cancer Research : MCR|December 22, 2025
Genetically engineered human iPS cell-derived kidney organoid recapitulates an early stage of ALK fusion gene-associated renal tumorigenesisGo Noguchi, Masaya Baba, Shinji Ohtake, et al.Pageof 1